Agomelatine Market Report

Global Agomelatine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：213
  • REPORT CODE：GMM768781
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Agomelatine market report explains the definition, types, applications, major countries, and major players of the Agomelatine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Novartis

    • Rovi Pharma

    • Jiangsu Haosen Pharmaceutical Group

    • Servier

    • Nectid Inc

    By Type:

    • Serotonin 2C Agonist

    • Melatonin Receptor 2 Agonist

    • Melatonin Receptor 1 Agonist

    • Serotonin Receptor Agonist

    • Serotonin 2C Receptor Antagonist

    By End-User:

    • Depression

    • Obsessive Compulsive Disorder

    • Sleep Disorders

    • Generalized Anxiety Disorder

    • Multiple Sclerosis

    • Systemic Traumatic Pain

    • Autism

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Agomelatine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Agomelatine Outlook to 2028- Original Forecasts

    • 2.2 Agomelatine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Agomelatine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Agomelatine Market- Recent Developments

    • 6.1 Agomelatine Market News and Developments

    • 6.2 Agomelatine Market Deals Landscape

    7 Agomelatine Raw Materials and Cost Structure Analysis

    • 7.1 Agomelatine Key Raw Materials

    • 7.2 Agomelatine Price Trend of Key Raw Materials

    • 7.3 Agomelatine Key Suppliers of Raw Materials

    • 7.4 Agomelatine Market Concentration Rate of Raw Materials

    • 7.5 Agomelatine Cost Structure Analysis

      • 7.5.1 Agomelatine Raw Materials Analysis

      • 7.5.2 Agomelatine Labor Cost Analysis

      • 7.5.3 Agomelatine Manufacturing Expenses Analysis

    8 Global Agomelatine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Agomelatine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Agomelatine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Agomelatine Market Outlook by Types and Applications to 2022

    • 9.1 Global Agomelatine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Serotonin 2C Agonist Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Melatonin Receptor 2 Agonist Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Melatonin Receptor 1 Agonist Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Serotonin Receptor Agonist Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Serotonin 2C Receptor Antagonist Consumption and Growth Rate (2017-2022)

    • 9.2 Global Agomelatine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Depression Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Obsessive Compulsive Disorder Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Sleep Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Generalized Anxiety Disorder Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Systemic Traumatic Pain Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Autism Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Agomelatine Market Analysis and Outlook till 2022

    • 10.1 Global Agomelatine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Agomelatine Consumption (2017-2022)

      • 10.2.2 Canada Agomelatine Consumption (2017-2022)

      • 10.2.3 Mexico Agomelatine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Agomelatine Consumption (2017-2022)

      • 10.3.2 UK Agomelatine Consumption (2017-2022)

      • 10.3.3 Spain Agomelatine Consumption (2017-2022)

      • 10.3.4 Belgium Agomelatine Consumption (2017-2022)

      • 10.3.5 France Agomelatine Consumption (2017-2022)

      • 10.3.6 Italy Agomelatine Consumption (2017-2022)

      • 10.3.7 Denmark Agomelatine Consumption (2017-2022)

      • 10.3.8 Finland Agomelatine Consumption (2017-2022)

      • 10.3.9 Norway Agomelatine Consumption (2017-2022)

      • 10.3.10 Sweden Agomelatine Consumption (2017-2022)

      • 10.3.11 Poland Agomelatine Consumption (2017-2022)

      • 10.3.12 Russia Agomelatine Consumption (2017-2022)

      • 10.3.13 Turkey Agomelatine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Agomelatine Consumption (2017-2022)

      • 10.4.2 Japan Agomelatine Consumption (2017-2022)

      • 10.4.3 India Agomelatine Consumption (2017-2022)

      • 10.4.4 South Korea Agomelatine Consumption (2017-2022)

      • 10.4.5 Pakistan Agomelatine Consumption (2017-2022)

      • 10.4.6 Bangladesh Agomelatine Consumption (2017-2022)

      • 10.4.7 Indonesia Agomelatine Consumption (2017-2022)

      • 10.4.8 Thailand Agomelatine Consumption (2017-2022)

      • 10.4.9 Singapore Agomelatine Consumption (2017-2022)

      • 10.4.10 Malaysia Agomelatine Consumption (2017-2022)

      • 10.4.11 Philippines Agomelatine Consumption (2017-2022)

      • 10.4.12 Vietnam Agomelatine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Agomelatine Consumption (2017-2022)

      • 10.5.2 Colombia Agomelatine Consumption (2017-2022)

      • 10.5.3 Chile Agomelatine Consumption (2017-2022)

      • 10.5.4 Argentina Agomelatine Consumption (2017-2022)

      • 10.5.5 Venezuela Agomelatine Consumption (2017-2022)

      • 10.5.6 Peru Agomelatine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Agomelatine Consumption (2017-2022)

      • 10.5.8 Ecuador Agomelatine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Agomelatine Consumption (2017-2022)

      • 10.6.2 Kuwait Agomelatine Consumption (2017-2022)

      • 10.6.3 Oman Agomelatine Consumption (2017-2022)

      • 10.6.4 Qatar Agomelatine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Agomelatine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Agomelatine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Agomelatine Consumption (2017-2022)

      • 10.7.2 South Africa Agomelatine Consumption (2017-2022)

      • 10.7.3 Egypt Agomelatine Consumption (2017-2022)

      • 10.7.4 Algeria Agomelatine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Agomelatine Consumption (2017-2022)

      • 10.8.2 New Zealand Agomelatine Consumption (2017-2022)

    11 Global Agomelatine Competitive Analysis

    • 11.1 Novartis

      • 11.1.1 Novartis Company Details

      • 11.1.2 Novartis Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Novartis Agomelatine Main Business and Markets Served

      • 11.1.4 Novartis Agomelatine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Rovi Pharma

      • 11.2.1 Rovi Pharma Company Details

      • 11.2.2 Rovi Pharma Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Rovi Pharma Agomelatine Main Business and Markets Served

      • 11.2.4 Rovi Pharma Agomelatine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Jiangsu Haosen Pharmaceutical Group

      • 11.3.1 Jiangsu Haosen Pharmaceutical Group Company Details

      • 11.3.2 Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Main Business and Markets Served

      • 11.3.4 Jiangsu Haosen Pharmaceutical Group Agomelatine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Servier

      • 11.4.1 Servier Company Details

      • 11.4.2 Servier Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Servier Agomelatine Main Business and Markets Served

      • 11.4.4 Servier Agomelatine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Nectid Inc

      • 11.5.1 Nectid Inc Company Details

      • 11.5.2 Nectid Inc Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Nectid Inc Agomelatine Main Business and Markets Served

      • 11.5.4 Nectid Inc Agomelatine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    12 Global Agomelatine Market Outlook by Types and Applications to 2028

    • 12.1 Global Agomelatine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Serotonin 2C Agonist Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Melatonin Receptor 2 Agonist Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Melatonin Receptor 1 Agonist Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Serotonin Receptor Agonist Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Serotonin 2C Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Agomelatine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Depression Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Obsessive Compulsive Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Generalized Anxiety Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Systemic Traumatic Pain Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Autism Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.8 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Agomelatine Market Analysis and Outlook to 2028

    • 13.1 Global Agomelatine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Agomelatine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Agomelatine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Agomelatine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Agomelatine Consumption Forecast (2022-2028)

      • 13.3.2 UK Agomelatine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Agomelatine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Agomelatine Consumption Forecast (2022-2028)

      • 13.3.5 France Agomelatine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Agomelatine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Agomelatine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Agomelatine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Agomelatine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Agomelatine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Agomelatine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Agomelatine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Agomelatine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Agomelatine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Agomelatine Consumption Forecast (2022-2028)

      • 13.4.3 India Agomelatine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Agomelatine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Agomelatine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Agomelatine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Agomelatine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Agomelatine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Agomelatine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Agomelatine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Agomelatine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Agomelatine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Agomelatine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Agomelatine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Agomelatine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Agomelatine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Agomelatine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Agomelatine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Agomelatine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Agomelatine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Agomelatine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Agomelatine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Agomelatine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Agomelatine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Agomelatine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Agomelatine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Agomelatine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Agomelatine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Agomelatine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Agomelatine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Agomelatine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Agomelatine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Agomelatine

    • Figure of Agomelatine Picture

    • Table Global Agomelatine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Agomelatine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Serotonin 2C Agonist Consumption and Growth Rate (2017-2022)

    • Figure Global Melatonin Receptor 2 Agonist Consumption and Growth Rate (2017-2022)

    • Figure Global Melatonin Receptor 1 Agonist Consumption and Growth Rate (2017-2022)

    • Figure Global Serotonin Receptor Agonist Consumption and Growth Rate (2017-2022)

    • Figure Global Serotonin 2C Receptor Antagonist Consumption and Growth Rate (2017-2022)

    • Figure Global Depression Consumption and Growth Rate (2017-2022)

    • Figure Global Obsessive Compulsive Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Sleep Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Generalized Anxiety Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure Global Systemic Traumatic Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Autism Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Agomelatine Consumption by Country (2017-2022)

    • Table North America Agomelatine Consumption by Country (2017-2022)

    • Figure United States Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Canada Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Agomelatine Consumption and Growth Rate (2017-2022)

    • Table Europe Agomelatine Consumption by Country (2017-2022)

    • Figure Germany Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure UK Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Spain Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure France Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Italy Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Finland Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Norway Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Poland Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Russia Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Agomelatine Consumption and Growth Rate (2017-2022)

    • Table APAC Agomelatine Consumption by Country (2017-2022)

    • Figure China Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Japan Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure India Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Agomelatine Consumption and Growth Rate (2017-2022)

    • Table South America Agomelatine Consumption by Country (2017-2022)

    • Figure Brazil Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Chile Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Peru Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Agomelatine Consumption and Growth Rate (2017-2022)

    • Table GCC Agomelatine Consumption by Country (2017-2022)

    • Figure Bahrain Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Oman Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Agomelatine Consumption and Growth Rate (2017-2022)

    • Table Africa Agomelatine Consumption by Country (2017-2022)

    • Figure Nigeria Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Agomelatine Consumption and Growth Rate (2017-2022)

    • Table Oceania Agomelatine Consumption by Country (2017-2022)

    • Figure Australia Agomelatine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Agomelatine Consumption and Growth Rate (2017-2022)

    • Table Novartis Company Details

    • Table Novartis Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Agomelatine Main Business and Markets Served

    • Table Novartis Agomelatine Product Portfolio

    • Table Rovi Pharma Company Details

    • Table Rovi Pharma Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rovi Pharma Agomelatine Main Business and Markets Served

    • Table Rovi Pharma Agomelatine Product Portfolio

    • Table Jiangsu Haosen Pharmaceutical Group Company Details

    • Table Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Haosen Pharmaceutical Group Agomelatine Main Business and Markets Served

    • Table Jiangsu Haosen Pharmaceutical Group Agomelatine Product Portfolio

    • Table Servier Company Details

    • Table Servier Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Servier Agomelatine Main Business and Markets Served

    • Table Servier Agomelatine Product Portfolio

    • Table Nectid Inc Company Details

    • Table Nectid Inc Agomelatine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nectid Inc Agomelatine Main Business and Markets Served

    • Table Nectid Inc Agomelatine Product Portfolio

    • Figure Global Serotonin 2C Agonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Melatonin Receptor 2 Agonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Melatonin Receptor 1 Agonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Serotonin Receptor Agonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Serotonin 2C Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Depression Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Obsessive Compulsive Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generalized Anxiety Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Systemic Traumatic Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autism Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Agomelatine Consumption Forecast by Country (2022-2028)

    • Table North America Agomelatine Consumption Forecast by Country (2022-2028)

    • Figure United States Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Agomelatine Consumption Forecast by Country (2022-2028)

    • Figure Germany Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Agomelatine Consumption Forecast by Country (2022-2028)

    • Figure China Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Agomelatine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Agomelatine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Agomelatine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Agomelatine Consumption Forecast by Country (2022-2028)

    • Figure Australia Agomelatine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Agomelatine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US